Log In
Wednesday 19th June 2019

Trial gout drug shows promise

2nd June 2011

A new drug currently involved in clinical trials has shown promise for the treatment of patients with gout.

The particularly painful form of inflammatory arthritis that develops when a substance called urate (uric acid) builds up and forms crystals in the joints. BCX4208 is an oral therapy designed to help lower levels of uric acid in the blood. According to the results of two phase-II studies, the drug can help to bring uric acid below the desired level when taken alongside the existing gout therapy allopurinol.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019